All Posts By

Smartkarma Daily Briefs

Daily Brief China: Alibaba Group, Lifestyle International Holdings, Agile Property Holdings, Adaro Energy and more

By | China, Daily Briefs

In today’s briefing:

  • Alibaba: Growth Avenues Are Closing Fast
  • Lifestyle Int’l (1212 HK): Thomas Yau Offer?
  • Chinese Property Weekly – 5 August 2022 – Lucror Analytics
  • Chinese Property Weekly – 5 August 2022 – Lucror Analytics
  • Weekly Wrap – 05 Aug 2022
  • Weekly Wrap – 05 Aug 2022

Alibaba: Growth Avenues Are Closing Fast

By Oshadhi Kumarasiri

  • Alibaba Group (9988 HK)’s 1QFY23 results were above consensus but it was still quite disappointing with revenue and OP declining 0.1% and 19.1% YoY respectively.
  • Withholding the disclosure of active buyers, which Alibaba was proudly speaking of in the previous quarter, is a tell-tale sign that the business is undergoing some serious trouble.
  • With expectations of 9.4% YoY OP growth in the next 3-quarters and 42% YoY OP growth in FY24, we think consensus is optimistic from 2QFY23 and bound for a correction.

Lifestyle Int’l (1212 HK): Thomas Yau Offer?

By David Blennerhassett

  • Lifestyle International Holdings (1212 HK) was suspended this morning pursuant to Hong Kong’s Takeovers Code. 
  • Thomas Lau is the largest shareholder with 74.97%, as he has been since April 2019.
  • A possible Offer ahead of a (potentially) improving retail outlook and the imminent opening of its Kai Tak project? 

Chinese Property Weekly – 5 August 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 5 August 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Weekly Wrap – 05 Aug 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Gajah Tunggal
  2. China Hongqiao
  3. Logan Property Holdings
  4. Sino-Ocean Group
  5. Softbank Group

and more…


Weekly Wrap – 05 Aug 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Gajah Tunggal
  2. China Hongqiao
  3. Logan Property Holdings
  4. Sino-Ocean Group
  5. Softbank Group

and more…


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief United States: Vertex Pharmaceuticals, 3 M Co, Hawkins Inc, Shenandoah Telecommunications Company, Howard Hughes Corp, Schlumberger Ltd, Texas Pacific Land Trust, Cadence Design Sys and more

By | Daily Briefs, United States

In today’s briefing:

  • Vertex Pharmaceuticals (VRTX US): Beat-And-Raise Q2 Results Driven by Strong Uptake of Trikafta
  • 3M Company: Innovation
  • HWKN: A Growth Story Continues
  • SHEN: Return of Debt
  • HHC: Operating Model Generating Income
  • Schlumberger NV: Increasing Exploration Activity
  • TPL: Multiple Revenue Streams
  • Cadence Design Systems Inc: The Future Facilities Acquisition & Other Drivers

Vertex Pharmaceuticals (VRTX US): Beat-And-Raise Q2 Results Driven by Strong Uptake of Trikafta

By Tina Banerjee

  • Vertex Pharmaceuticals (VRTX US) reported strong Q2 results, with both revenue and adjusted EPS surpassing consensus. Flagship drug, Trikafta reported 51% y/y revenue growth and contributed 86% of revenue.
  • Vertex estimates more than 25K CF patients that are addressable with its Trikafta are still untreated, thereby providing sustainable growth opportunities. No immediate competition is seen.
  • The company lifted 2022 product revenue guidance by 2% at the mid-point to $8.6–8.8 billion. R&D costs are also expected to remain elevated as multiple ongoing clinical trials.

3M Company: Innovation

By Ishan Majumdar

  • Apart from being known as one of the most innovative companies in today’s times, 3M also has a strong reputation of successful restructuring and cost management which has helped the industrial conglomerate survive through many challenging business cycles.
  • The company continues to benefit from strong spending discipline, restructuring savings, and selling price actions.
  • We provide the stock of 3M Company with a ‘Hold’ rating with a revision in the target price.

HWKN: A Growth Story Continues

By Hamed Khorsand

  • HWKN reported fiscal first quarter (June) results where continued price increases resulted in the Company reporting higher sales and earnings compared to our estimates
  • HWKN operates a business where the increase in sales generates higher gross profit dollars with minimal change in operating expenses
  • HWKN reported sales of $246.5 million compared to our forecast of $209.9 million. A LIFO charge of $3.8 million was lower and led to EPS beating our estimate

SHEN: Return of Debt

By Hamed Khorsand

  • SHEN reported a narrower than expected operating loss for the second quarter as revenue increased from first quarter levels. 
  • SHEN has started to see an increase in the number of Glo Fiber subscribers as the Company ramps up its fiber buildout
  • SHEN drew on its credit facility in July and expects to draw additional capital before the end of the year. The return of leverage could lead to a lower valuation.

HHC: Operating Model Generating Income

By Hamed Khorsand

  • HHC delivered discernable second quarter 2022 results of progress in a pivot from landowners to landowners and operators
  • Q2 results displayed how HHC’s business model can work. HHC’s operating assets within MPCs are generating a higher level of income as the MPCs’ population have increased
  • HHC’s decision to pivot to operating assets in MPCs continued the trend of giving investors another value point

Schlumberger NV: Increasing Exploration Activity

By Ishan Majumdar

  • Schlumberger has benefitted from the growing oil industry activity by leveraging the strength of its core, its global reach, and its technology, showcasing its capacity to seize growth in every land and offshore basin.
  • The management also reports substantial offshore and onshore growth in North America’s increased drilling and completion activity.
  • Besides, their second quarter sequential growth in most regions and in support of all divisions was largely due to the increase in offshore activity, particularly deepwater.

TPL: Multiple Revenue Streams

By Hamed Khorsand

  • TPL reported second quarter results exceeding our expectations as the increase in activity in the Permian Basin resulted in higher revenue across all segments. 
  • TPL is benefiting from higher oil and gas prices enticing energy companies to boost production
  • The second quarter results did not show a rebound in overall barrels of oil equivalent (“BOE”) as we had hoped would be the case from the first quarter results.

Cadence Design Systems Inc: The Future Facilities Acquisition & Other Drivers

By Ishan Majumdar

  • Digital transformation is accelerating across various industries thanks to generational trends like 5G, hyperscale computing, and autonomous vehicles supported by AI, ML, and data analytics.
  • These trends are boosting design activity, creating a strong secular tailwind for the core end-to-end EDA, IP, and expanding systems portfolio.
  • Cadence also acquired Future Facilities during the quarter to expand its CFD portfolio to include data centres.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Most Read: Oriental Land, SJM Holdings, PT Metrodata Electronics, Semirara Mining And Power Corp, Alibaba Group, JD Health, Canon Inc, Lifestyle International Holdings, Link Administration and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Nikkei 225 Index Rebalance Preview: Consultation Conclusions & Potential Changes in Sep & March
  • SJM Holdings (880 HK) Rights Issue – Capital Raise, Unappreciated, but Interesting Trading Dynamics
  • Smartkarma Corporate Webinar | Metrodata Electronics: Rising with the Digital Tide
  • PCOMP Index Rebalance: Semirara Mining (SCC) Replaces Security Bank (SECB)
  • Alibaba (9988 HK): Zero Growth for First Time, But Overly Sold, Buy
  • FTSE China 50 Index Rebalance Preview: One Change in Range, Couple Others Close
  • Alibaba: Growth Avenues Are Closing Fast
  • Canon (7751) – Second Buyback This Year – Last Happened in 2014
  • Lifestyle Int’l (1212 HK): Thomas Yau Offer?
  • Link Admin: Dye & Durham Offers To Sell Aussie Ops To Appease ACCC

Nikkei 225 Index Rebalance Preview: Consultation Conclusions & Potential Changes in Sep & March

By Brian Freitas

  • With the review period for the September rebalance of the Nikkei 225 (NKY INDEX) complete, we take a look at the potential inclusions and exclusions for the index.
  • The conclusions of the market consultation have been announced and that will mean we switch to a semi-annual rebalance. So we take a look at potential changes in March 2023.
  • The announcement of the changes for the next rebalance should be made in the first week of September and will be implemented at the close on 30 September.

SJM Holdings (880 HK) Rights Issue – Capital Raise, Unappreciated, but Interesting Trading Dynamics

By Travis Lundy

  • SJM Holdings (880 HK) announced earnings on Monday and a HK$3bn Rights Issue last night designed to inject capital into Macau gaming licensee SJM Resorts. 
  • An increase in share capital is required to pre-qualify for then tender process where the Macau Govt would allocate a 10-year gaming concession starting 1 Jan 2023. 
  • 54.7% SJM Holder/Parent Sociedade de Turismo e Diversões de Macau (STDM) had previously extended a loan to SJM designed to allow SJM to inject capital to SJM Resorts.

Smartkarma Corporate Webinar | Metrodata Electronics: Rising with the Digital Tide

By Smartkarma Research

For our next Corporate Webinar we are glad to welcome Metrodata Electronics’ President Director/CEO, Susanto Djaja and Director/CFO, Randy Kartadinata.

In the upcoming webinar, Susanto will share a short company presentation after which, he and Randy will engage in a fireside chat with Smartkarma Insight Provider, Angus Mackintosh. The Corporate Webinar will include a live Q&A session.

The Corporate Webinar will be hosted on Tuesday, 16 August 2022, 17:00 SGT.

PT Metrodata Electronics, Tbk (MTDL:IJ), publicly listed company on Indonesia Stock Exchange since 1990, is a Digital Solution Provider and Technology Innovator in Indonesia that leads and enables the digital economy hub. MTDL builds strategic alliances with world-class ICT companies. The Company has two main business units, including Distribution Business (providing World-Class ICT Hardware and Software) that handles distribution through Omnichannel to partnered dealers (both offline and online) and ICT solution companies, as well as runs an e-commerce business (e-catalogue for Government/B2G). Its Distribution network covers more than 150 cities in Indonesia and has more than 5,200 channel partners and more than 100 world-class IT products and service brands. The second business unit, Solution & Consulting Business, is a digital solution provider that provides a complete range of ICT solutions based on Metrodata’s 8 Pillars of Digital Solutions, which consist of Cloud Services, Big Data & Analytics, Hybrid IT Infrastructure, Security, Business Application, Digital Business Platform, Consulting & Advisory Services, and Managed Services to support digital business transformation, for Enterprise, Corporate, SME, and Public Sector segment.

Corporate Webinars by Smartkarma Corporate Solutions feature discussions with IROs and Executives, discussing their companies, the challenges they face, and the opportunities in their sectors and markets.


PCOMP Index Rebalance: Semirara Mining (SCC) Replaces Security Bank (SECB)

By Brian Freitas


Alibaba (9988 HK): Zero Growth for First Time, But Overly Sold, Buy

By Ming Lu

  • Alibaba’s revenue stopped growing for the first time on record.
  • We still believe the revenue growth rate will recover in the December quarter.
  • We believe the stock price will have at least an upside of 29% after a significant plunge.

FTSE China 50 Index Rebalance Preview: One Change in Range, Couple Others Close

By Brian Freitas

  • Shenzhou Intl Group Holdings (2313 HK) is a high probability deletion in September, while JD Health (6618 HK) is currently the highest ranked non-constituent stock.
  • There are a couple of other stocks that are close to the inclusion/exclusion thresholds and price changes over the next few weeks will determine if there are any more changes.
  • Short interest on JD Health (6618 HK) is high in terms of days to cover and as a percentage of free float. Covering could take the stock higher.

Alibaba: Growth Avenues Are Closing Fast

By Oshadhi Kumarasiri

  • Alibaba Group (9988 HK)’s 1QFY23 results were above consensus but it was still quite disappointing with revenue and OP declining 0.1% and 19.1% YoY respectively.
  • Withholding the disclosure of active buyers, which Alibaba was proudly speaking of in the previous quarter, is a tell-tale sign that the business is undergoing some serious trouble.
  • With expectations of 9.4% YoY OP growth in the next 3-quarters and 42% YoY OP growth in FY24, we think consensus is optimistic from 2QFY23 and bound for a correction.

Canon (7751) – Second Buyback This Year – Last Happened in 2014

By Travis Lundy

  • Canon Inc (7751 JP) reported Q2 earnings early last week. Shares dropped 4% the next day but closed down only 1%. Now they are above the prior close. 
  • They biked the dividend nicely (was ¥45/share last year, guided to ¥50 this year, but made ¥60/share instead. 
  • And now they have announced another ¥50bn buyback on top of the one announced in May. Fourth time in 14 years a second tranche is announced in one year. 

Lifestyle Int’l (1212 HK): Thomas Yau Offer?

By David Blennerhassett

  • Lifestyle International Holdings (1212 HK) was suspended this morning pursuant to Hong Kong’s Takeovers Code. 
  • Thomas Lau is the largest shareholder with 74.97%, as he has been since April 2019.
  • A possible Offer ahead of a (potentially) improving retail outlook and the imminent opening of its Kai Tak project? 

Link Admin: Dye & Durham Offers To Sell Aussie Ops To Appease ACCC

By David Blennerhassett

  • The ACCC is seeking views on whether Dye & Durham’s proposed sale of GlobalX and the Australian operations of SAI Global, is sufficient to approve Link Administration (LNK AU)‘s takeover.
  • Separately, the postponed Scheme meeting will be held on the 22 August.  The Independent Expert continues to conclude that the Revised Scheme is fair and reasonable.
  • The proposed date for the announcement of ACCC’s findings is the 8th September, one day prior to the Second Court Date.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Technical Analysis: Xiaomi and more

By | Daily Briefs, Technical Analysis

In today’s briefing:

  • Xiaomi, China Unicom, and Bank Of China

Xiaomi, China Unicom, and Bank Of China

By Untying The Gordian Knot

  • The Hong Kong Indices have been much weaker than Taiwan & China due to liquidity and open capital account.
  • It is a canary for global indices and should be analyzed accordingly.
  • There is no change in views of real estate and technology sector stocks mentioned in previous updates on Hang Seng constituents.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ESG: Share Buybacks Exceed BOJ’s ETF Purchases and more

By | Daily Briefs, ESG

In today’s briefing:

  • Share Buybacks Exceed BOJ’s ETF Purchases, but BOJ’s Presence Is Significant in Another Aspect

Share Buybacks Exceed BOJ’s ETF Purchases, but BOJ’s Presence Is Significant in Another Aspect

By Aki Matsumoto

  • Of course, When the BOJ’s ETF purchases were active, there were concerns about their impact on stock price formation, but now the impact is much smaller.
  • However, the BOJ has a presence in listed companies as a silent major shareholder, it is highly questionable whether its voting rights are being properly exercised.
  • While the silent major shareholder exists, overseas investors have played major role in enhancing corporate governance. In addition to cross-shareholding structures, they also have to contend with the silent shareholder.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Credit: Morning Views Asia: Adaro Minerals and more

By | Credit, Daily Briefs

In today’s briefing:

  • Morning Views Asia: Adaro Minerals, China Hongqiao, Gajah Tunggal, Sino-Ocean Service

Morning Views Asia: Adaro Minerals, China Hongqiao, Gajah Tunggal, Sino-Ocean Service

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Event-Driven: SJM Holdings (880 HK) Rights Issue – Capital Raise and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • SJM Holdings (880 HK) Rights Issue – Capital Raise, Unappreciated, but Interesting Trading Dynamics
  • Hoya (7741) – Record Revenues/Earnings, a Small Buyback, but Nikkei 225 Flows May Dominate
  • CK Group Wants to Sell Its Stake in AMTD Group
  • MicroStrategy (MSTR US): Saylor Mirrors Bitcoin’s Fall
  • ResApp’s Revised Offer from Pfizer Still Faces Headcount Test Risk
  • FTSE China 50 Index Rebalance Preview: One Change in Range, Couple Others Close
  • Della Valle/Tod’s: Lowball Minorities Buyout
  • Bunka Shutter (5930 JP) – Big Buyback Vs Big CB Means No Accretion, Minimal Flow Impact

SJM Holdings (880 HK) Rights Issue – Capital Raise, Unappreciated, but Interesting Trading Dynamics

By Travis Lundy

  • SJM Holdings (880 HK) announced earnings on Monday and a HK$3bn Rights Issue last night designed to inject capital into Macau gaming licensee SJM Resorts. 
  • An increase in share capital is required to pre-qualify for then tender process where the Macau Govt would allocate a 10-year gaming concession starting 1 Jan 2023. 
  • 54.7% SJM Holder/Parent Sociedade de Turismo e Diversões de Macau (STDM) had previously extended a loan to SJM designed to allow SJM to inject capital to SJM Resorts.

Hoya (7741) – Record Revenues/Earnings, a Small Buyback, but Nikkei 225 Flows May Dominate

By Travis Lundy

  • Hoya Corp (7741 JP) today announced great Q1 earnings and a bullish above-consensus revenue forecast for this fiscal year. It also announced a small share buyback. 
  • However, the dominant factor in flows near-term will be pre-positioning for a possible Nikkei 225 inclusion in September. That is what will push the stock around. In or not. 
  • Hoya has recently outperformed a Peer Basket despite forward expected EPS and EBIT not seeing relative improvement. That suggests some relative risk if it doesn’t get selected for Nikkei 225.

CK Group Wants to Sell Its Stake in AMTD Group

By Douglas Kim

  • AMTD Digital’s stock price has started to sink and now there are news that the Cheung Kong (CK) Group (HK) wants to sell its stake in AMTD Group Co.
  • The discussion of the CK Group disposing its stake in AMTD Group altogether is likely to further negatively impact AMTD Digital’s share price.
  • Li Ka-Shing and his family probably want to distance themselves from all the unnecessary media attention given to AMTD Digital (HKD US) and AMTD Idea Group (AMTD US). 

MicroStrategy (MSTR US): Saylor Mirrors Bitcoin’s Fall

By David Blennerhassett

  • Microstrategy Inc (MSTR US)‘s Michael Saylor will now assume the new role of Executive Chairman and Phong Le, MSTR’s President, will serve as the company’s new CEO.
  • As Executive Chairman, Saylor will focus more on MSTR’s bitcoin acquisition strategy and related bitcoin advocacy initiatives.
  • With one of the most bullish and influential players in the industry now focusing on crypto, this should be considered bullish, according to some media reports. That’s a desperate takeaway.

ResApp’s Revised Offer from Pfizer Still Faces Headcount Test Risk

By Arun George

  • Pfizer Inc (PFE US) upped its Resapp Health (RAP AU) offer from A$0.146 per share to A$0.208 per share, in line with the independent expert’s preferred value of A$0.208 per share.
  • The NO vote camp from defiant retail shareholders forced Pfizer to up its offer. Unfortunately, a vocal NO camp is still present despite Pfizer’s revised higher offer.
  • At the last close, the gross spread is 9.5%. The risk/reward profile is unfavourable as ResApp is a highly-held retail stock, posing a headcount test risk to the scheme.  

FTSE China 50 Index Rebalance Preview: One Change in Range, Couple Others Close

By Brian Freitas

  • Shenzhou Intl Group Holdings (2313 HK) is a high probability deletion in September, while JD Health (6618 HK) is currently the highest ranked non-constituent stock.
  • There are a couple of other stocks that are close to the inclusion/exclusion thresholds and price changes over the next few weeks will determine if there are any more changes.
  • Short interest on JD Health (6618 HK) is high in terms of days to cover and as a percentage of free float. Covering could take the stock higher.

Della Valle/Tod’s: Lowball Minorities Buyout

By Jesus Rodriguez Aguilar

  • The Della Valles offer €40/share (1.8 EV/Fwd Sales, c.20% premium) to buy out the minorities (LVMH stays a 10% shareholder). Minimum acceptance condition is 90%, aiming at 60.9% of  float.
  • Tod’s is in turnaround mode (my valuation assumes it’ll be successful). A DCF valuation gives €52.21/share, a break-up valuation could reach €57.12/share, while a simpler 2.0x EV/Fwd Sales throws €43.02/share.
  • The shares trade above the offer and a sweetening may be needed; the offer price seems cheap on any measure. A template could be the acquisition of Creval. Long.

Bunka Shutter (5930 JP) – Big Buyback Vs Big CB Means No Accretion, Minimal Flow Impact

By Travis Lundy

  • Today Bunka Shutter (5930 JP) reported iffy, if predictably seasonal Q1 earnings, and FY22 forecasts. They also announced a big buyback which caused the stock to pop, then come back.
  • It came back because the stock has a decently large slightly in-the-money CB with 13 months to maturity. A big pop will get a big re-hedge.
  • Over the next year, despite the large buyback, EPS accretion and net buyback flow impact should be minimal. And the stock isn’t as cheap as it “looks.”

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Giant Biogene Pre-IPO – The Negatives – Co-Founders Have Already Cashed in US$1bn+ and more

By | Daily Briefs, ECM

In today’s briefing:

  • Giant Biogene Pre-IPO – The Negatives – Co-Founders Have Already Cashed in US$1bn+
  • Hongjiu Fruit IPO: A Bitter Fruit
  • Sai Silk Kalamandir Pre-IPO Tearsheet
  • Biocytogen (百奥赛图) Pre-IPO: Prospectus and Valuation Updates
  • Pre-IPO Cali Biosciences – The Industry, the Business and the Concerns

Giant Biogene Pre-IPO – The Negatives – Co-Founders Have Already Cashed in US$1bn+

By Sumeet Singh

  • Giant Biogene (GB) aims to raise around US$500m in its Hong Kong IPO.
  • GB is a leader in the bioactive ingredient-based professional skin treatment product industry in China.
  • In this note, we talk about the not-so-positive aspects of the deal.

Hongjiu Fruit IPO: A Bitter Fruit

By Arun George

  • Chongqing Hongjiu Fruit (CHF HK), a multi-brand fruit company in China, is pre-marketing an HKEX IPO to raise US$200-300 million.
  • The fundamentals are uninspiring as it is delivering profitable growth with a heavy cash burn. The rising but tiny market share suggests a lack of sustainable competitive advantage.
  • Hongjiu Fruit aims to be the first HKEx-listed fruit distributor. Investors can likely avoid a bitter aftertaste by remaining on the sidelines.

Sai Silk Kalamandir Pre-IPO Tearsheet

By Ethan Aw

  • Sai Silk Kalamandir (SSKL IN) is looking to raise about US$150m in its upcoming India IPO. The deal will be run by Motilal Oswal, Edelweiss and HDFC Bank. 
  • Sai Silk Kalamandir (SSK) is one of the largest retailers of ethnic apparel in South India, particularly in sarees, according to Technopak. 
  • Through its four store formats, it offers ethnic and value fashion products to various segments across different price points. As of 31 May 2022, it has 46 network stores. 

Biocytogen (百奥赛图) Pre-IPO: Prospectus and Valuation Updates

By Ke Yan, CFA, FRM

  • Biocytogen, a China-based pre-clinical research and biopharmaceutical company, will pre-market its IPO to raise USD 25m, which is a significant downsize from the previous USD 300m fundraising target.
  • In our previous note, we covered the company’s fundamentals and compared its business with its peers.
  • We will provide an update on its latest prospectus and its peer performance in this note.

Pre-IPO Cali Biosciences – The Industry, the Business and the Concerns

By Xinyao (Criss) Wang

  • Both the postoperative pain management and the expansive application of anesthetics in various fields would increase the market demand for ropivacaine.
  • Cali Biosciences (CALI HK)’s core product, the ropivacaine long-acting analgesic injection drug candidate CPL-01, would have to face the challenges of fierce competition, uncertain market acceptance, and negative policy impact.
  • Together with other concerns such as slow development progress, “not rich enough” pipeline and potential liquidity risk, we are conservative about Cali’s outlook at the current stage.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Private Markets: PhonePe Tearsheet – India’s SuperApp Ambition and more

By | Daily Briefs, Private Markets

In today’s briefing:

  • PhonePe Tearsheet – India’s SuperApp Ambition

PhonePe Tearsheet – India’s SuperApp Ambition

By Pranav Bhavsar

  • Phonepe Pvt Ltd (1732974D IN) runs a digital payment and technology App in India and is currently the leader in terms of UPI transactions processed. 
  • Our channel feedback suggests the possible disruption from initiatives like ONDC to be positive for payment apps like PhonePe, with the possible acceleration towards the SuperApp Journey. 
  • Revenues are always growing, and so are losses. With ONDC, there is a possibility this may change faster than anticipated and hence warrants close attention. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Thematic (Sector/Industry): Investigating a Surge in AUM of Local Battery ETFs & Ongoing Sector Rally and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Investigating a Surge in AUM of Local Battery ETFs & Ongoing Sector Rally

Investigating a Surge in AUM of Local Battery ETFs & Ongoing Sector Rally

By Sanghyun Park

  • Money is again pouring into local rechargeable battery-themed ETFs. The AUMs of the major battery ETFs have increased by 20-35% over the past month.
  • The passive flow added in the past month to x ADTV was significant. The increase in the ETF AUM must have acted as a factor that aggravated the sector rally.
  • The current rally will closely correlate with AUM’s growth pace. A 10% increase in AUM introduces a passive flow, on average, equivalent to 0.3-0.4x ADTV.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars